Comparación de la efectividad de dos colutorios en pacientes oncológicos pediátricos en el Hospital del Niño Dr. Francisco de Icaza Bustamante
Fecha
2021
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Químicas
Resumen
Las enfermedades catastróficas representan un tema de evidenciable interés en Salud Pública; por la pérdida de vidas humanas y los altos recursos económicos que este padecimiento demanda. La mucositis oral es el efecto del tratamiento antineoplásico por quimioterapia o radioterapia. Por lo que, el objetivo de la investigación fue determinar la eficacia de una fórmula magistral (Solución Stanford A y B) mediante un instructivo de uso en pacientes pediátricos con mucositis oral post tratamiento con quimioterápicos para la minimización de sus complicaciones clínicas en el Hospital del Niño Dr. Francisco de Icaza Bustamante. El tipo de investigación es descriptiva-experimental con enfoque cualitativo de tipo correlacional; dirigida a 137 pacientes ingresados durante el periodo octubre 2020 a marzo 2021. Su principal hallazgo fue, una solución Stanford B que contribuye a tener una recuperación más rápida en pacientes con mucositis oral en la post quimioterapia y que mejora las condiciones clínicas que presenta el paciente. Se concluyó que, uno de los componentes clave para la reducción de la mucositis oral es el planteamiento de protocolos de cuidado bucal y en la educación del paciente. Y, particularmente brindar educación farmacéutica a los cuidadores de pacientes pediátricos.
Catastrophic diseases represent a subject of evident interest in Public Health; due to the loss of human lives and the high economic resources that this condition demands. Oral mucositis is the effect of antineoplastic treatment by chemotherapy or radiotherapy. Therefore, the objective of the research was to determine the effectiveness of a magisterial formula (Stanford Solution A and B) by means of an instruction manual for use in pediatric patients with oral mucositis after treatment with chemotherapeutic drugs to minimize their clinical complications at Hospital del Hospital. Child Dr. Francisco de Icaza Bustamante. The type of research is descriptive-experimental with a correlational qualitative approach; aimed at 137 patients admitted during the period October 2020 to March 2021. Its main finding was a Stanford B solution that contributes to a faster recovery in patients with oral mucositis in post-chemotherapy and improves the clinical conditions presented by the patient. It was concluded that one of the key components for the reduction of oral mucositis is the approach to oral care protocols and patient education. And, particularly to provide pharmaceutical education to caregivers of pediatric patients.
Catastrophic diseases represent a subject of evident interest in Public Health; due to the loss of human lives and the high economic resources that this condition demands. Oral mucositis is the effect of antineoplastic treatment by chemotherapy or radiotherapy. Therefore, the objective of the research was to determine the effectiveness of a magisterial formula (Stanford Solution A and B) by means of an instruction manual for use in pediatric patients with oral mucositis after treatment with chemotherapeutic drugs to minimize their clinical complications at Hospital del Hospital. Child Dr. Francisco de Icaza Bustamante. The type of research is descriptive-experimental with a correlational qualitative approach; aimed at 137 patients admitted during the period October 2020 to March 2021. Its main finding was a Stanford B solution that contributes to a faster recovery in patients with oral mucositis in post-chemotherapy and improves the clinical conditions presented by the patient. It was concluded that one of the key components for the reduction of oral mucositis is the approach to oral care protocols and patient education. And, particularly to provide pharmaceutical education to caregivers of pediatric patients.
Descripción
Pdf
Palabras clave
MUCOSITIS ORAL, COLUTORIOS, CLORHEXIDINA, SOLUCIÓN STANFORD A Y B, TRATAMIENTO ANTINEOPLÁSICO, QUIMIOTERAPIA